Skip to content

Effects of Lactobacillus acidophilus on insulin resistance in obese patients with polycystic ovary syndrome: a randomized controlled clinical study

Effects of Lactobacillus acidophilus on insulin resistance in obese patients with polycystic ovary syndrome: a randomized controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076223
Enrollment
Unknown
Registered
2023-09-27
Start date
2023-02-07
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovarian syndrome

Interventions

Intervention group:Lactobacillus acidophilus+melbine (DMBG)

Sponsors

Reproductive Center, the Second Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients with PCOS with obesity (BMI >= 28kg/?) and insulin resistance index (HOMA-IR) greater than or equal to 2.69; 2. Women of childbearing age, aged 18-40 years; 3. No drugs affecting menstruation (such as contraceptives, hormones or other drugs affecting insulin, blood sugar, sex hormones and lipid metabolism) were taken within 3 months, and no related treatment was used, and no induced abortion was recorded; 4. Gynecological examination and auxiliary examination: there are no organic lesions in the internal and external genitalia, and there are no other primary diseases; 5. Those who have signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Combined with other endocrine diseases, such as diabetes, thyroid disease, secreting sex hormone tumors, etc; 2. Physical diseases associated with severe or unstable states, including diseases of the liver, kidney, cardiovascular, respiratory, nervous or blood system, autoimmune diseases, etc., psychiatric patients; 3. Have a history of thromboembolic disease or a tendency to thrombosis; 4. Women who smoke or drink heavily; 5. Lactating or pregnant women; 6. Women with a history of other malignant tumors; 7. Use of statins/antibiotics/Lactobacillus acidophilus products/Chinese medicines/antiandrogens/insulin sensitizers or other drugs known or suspected to affect reproductive or metabolic function within the last 3 months; 8. Special physique, allergic to drugs; 9. Patients who need to be treated in other aspects in addition to the disease, which affects the study and cannot be carried out according to the study protocol; 10. There are congenital deficiencies in the reproductive system that cannot meet the needs of this study.

Design outcomes

Primary

MeasureTime frame
Insulin resistance;Six items of sexual hormones;

Secondary

MeasureTime frame
Liver function;Menstrual cycle;Height and weight;

Countries

China

Contacts

Public ContactLiu Zhaoxia

The Second Affiliated Hospital of Nanchang University

lzxia77@163.com+86 138 7090 3849

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026